Nova Eye Medical Stock Market Value
| ELXMF Stock | USD 0 0.00 0.00% |
| Symbol | Nova |
Nova Eye 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nova Eye's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nova Eye.
| 07/20/2025 |
| 01/16/2026 |
If you would invest 0.00 in Nova Eye on July 20, 2025 and sell it all today you would earn a total of 0.00 from holding Nova Eye Medical or generate 0.0% return on investment in Nova Eye over 180 days. Nova Eye is related to or competes with PetVivo Holdings, Novacyt SA, Positron Corp, and Perimeter Medical. Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment... More
Nova Eye Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nova Eye's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nova Eye Medical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 98.1 |
Nova Eye Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Eye's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nova Eye's standard deviation. In reality, there are many statistical measures that can use Nova Eye historical prices to predict the future Nova Eye's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (1.56) | |||
| Total Risk Alpha | (3.23) | |||
| Treynor Ratio | (2.44) |
Nova Eye Medical Backtested Returns
Nova Eye Medical has Sharpe Ratio of -0.13, which conveys that the firm had a -0.13 % return per unit of risk over the last 3 months. Nova Eye exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nova Eye's Standard Deviation of 12.08, risk adjusted performance of (0.08), and Mean Deviation of 2.93 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.61, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Nova Eye's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nova Eye is expected to be smaller as well. At this point, Nova Eye Medical has a negative expected return of -1.56%. Please make sure to verify Nova Eye's standard deviation, as well as the relationship between the maximum drawdown and day median price , to decide if Nova Eye Medical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Nova Eye Medical has no correlation between past and present. Overlapping area represents the amount of predictability between Nova Eye time series from 20th of July 2025 to 18th of October 2025 and 18th of October 2025 to 16th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nova Eye Medical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Nova Eye price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Nova Eye Medical lagged returns against current returns
Autocorrelation, which is Nova Eye pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nova Eye's pink sheet expected returns. We can calculate the autocorrelation of Nova Eye returns to help us make a trade decision. For example, suppose you find that Nova Eye has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nova Eye regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nova Eye pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nova Eye pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nova Eye pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Nova Eye Lagged Returns
When evaluating Nova Eye's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nova Eye pink sheet have on its future price. Nova Eye autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nova Eye autocorrelation shows the relationship between Nova Eye pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Nova Eye Medical.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Nova Pink Sheet
Nova Eye financial ratios help investors to determine whether Nova Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Eye security.